Clinical Trials Directory

Trials / Completed

CompletedNCT01075919

Cognitive and Mood Effects of Docosahexaenoic Acid (DHA)-Rich and Eicosapentaenoic Acid (EPA)-Rich Fish Oil in Healthy Young Adults

Cognitive and Mood Effects of DHA-rich and EPA-rich Fish Oil in Healthy Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
159 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To date, only a small handful of studies have assessed the effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cognitive function in healthy adults. The results from these studies are mixed, and have differed greatly in terms of methodology as regards sample size, treatment formulation and duration of the intervention. In order to address these issues, the present study aims to assess the effects of two different formulations of fish oil in parallel, and at doses consistent with the current recommended daily intake of oily fish, across a range of cognitive domains. The aim of the present investigation is therefore to specifically evaluate the effects of 12 weeks supplementation of DHA-rich fish oil and EPA-rich fish oil dietary supplements on cognitive function in healthy young adults maintaining a regular diet containing oily fish not more than once a week. Self-report mood assessments will form the secondary part of this investigation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTn-3 PUFAs1 g DHA-rich fish oil taken daily for 12 weeks
DIETARY_SUPPLEMENTPlacebo1 g olive oil taken daily for 12 weeks
DIETARY_SUPPLEMENTn-3 PUFAs1 g EPA-rich fish oil taken daily for 12 weeks

Timeline

Start date
2007-12-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2010-02-25
Last updated
2010-02-25

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01075919. Inclusion in this directory is not an endorsement.